1.
Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
by Eriksson, Jan W
Diabetologia, 2018, Vol.61 (9), p.1923-1934
2.
3.
Cyclosporine A and Tacrolimus Reduce the Amount of GLUT4 at the Cell Surface in Human Adipocytes: Increased Endocytosis as a Potential Mechanism for the Diabetogenic Effects of Imm...
by Pereira, Maria J
The journal of clinical endocrinology and metabolism, 2014, Vol.99 (10), p.E1885-E1894
4.
The effect of polymorphisms in the renin–angiotensin–aldosterone system on diabetic nephropathy risk
by Möllsten, Anna
Journal of diabetes and its complications, 2008, Vol.22 (6), p.377-383
5.
Hydrochlorothiazide, but not Candesartan, Aggravates Insulin Resistance and Causes Visceral and Hepatic Fat Accumulation: The Mechanisms for the Diabetes Preventing Effect of Cande...
by Eriksson, Jan W
Hypertension (Dallas, Tex. 1979), 2008, Vol.52 (6), p.1030-1037
6.
Early changes in glomerular size selectivity in young adults with type 1 diabetes and retinopathy. Results from the Diabetes Incidence Study in Sweden
by Torffvit, Ole
Journal of diabetes and its complications, 2007, Vol.21 (4), p.246-251
7.
Response to Distinct Metabolic Effects of Different Classes of Antihypertensive Drugs
by Eriksson, Jan W
Hypertension (Dallas, Tex. 1979), 2009, Vol.53 (4), p.e27-e27
8.
Insulin Receptor Substrates-1 and -2 Are Both Depleted but via Different Mechanisms after Down-Regulation of Glucose Transport in Rat Adipocytes
by Renström, Frida
Endocrinology (Philadelphia), 2005, Vol.146 (7), p.3044-3051
9.
Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'
by LUNDGREN, M
Diabetologia, 2007, Vol.50 (3), p.625-633
10.
Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects : results from the nationwide Diabetes Incid...
by LITTORIN, B
Diabetologia, 2006, Vol.49 (12), p.2847-2852
11.
The risk of venous thromboembolism is markedly elevated in patients with diabetes
by PETRAUSKIENE, V
Diabetologia, 2005, Vol.48 (5), p.1017-1021
12.
Estrogen and glucocorticoid effects on lipocalin 2 expression in human adipose tissue: A role of ER beta pathway in insulin resistance?
by Kamble, Prasad G
Diabetologia, 2018, Vol.61, p.S289
13.
Glucocorticoids Down-Regulate Glucose Uptake Capacity and Insulin-Signaling Proteins in Omental But Not Subcutaneous Human Adipocytes
by Lundgren, M
The journal of clinical endocrinology and metabolism, 2004, Vol.89 (6), p.2989-2997
14.
Calcineurin is involved in the regulation of human adipocyte glucose uptake
by Fonseca, Ana R. G
Diabetologia, 2017, Vol.60, p.S227
15.
16.
17.
Soluble CD36 (sCD36) Clusters with Markers of Insulin Resistance, and High sCD36 Is Associated with Increased Type 2 Diabetes Risk
by Handberg, A
The journal of clinical endocrinology and metabolism, 2010, Vol.95 (4), p.1939-1946
18.
FKBP51 ablation using CRISPR/Cas-9 impairs adipocyte differentiation
by Castillejo-Lopez, Casimiro
Diabetologia, 2018, Vol.61, p.S11
19.
One year of treatment with dapagliflozin QD plus exenatide QW in obese adults without diabetes: results of an open-label extension study
by Eriksson, Jan W
Diabetologia, 2016, Vol.59, p.S332
20.
The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983 to 1998
by PUNDZIUTE-LYCKA, A
Diabetologia, 2002, Vol.45 (6), p.783-791
